 | • レポートコード：GIR-105X10300 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、レボノルゲストレルAPIのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。レボノルゲストレルAPIの種類別市場規模（短時間作用型避妊API、長時間作用型避妊API）、用途別市場規模（テーブル、混合物製品、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・レボノルゲストレルAPIの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：ScinoPharm、Altaris (3M Drug Delivery Systems)、Bayer、Cipla、Formos、FORTEQ NIDAU AG、Gedeon Richter、Hangzhou Longshine Bio-Tec、Hubei Gedian Humanwell Pharmaceutical、Indo Phyto Chemicals、Industriale Chimica、Jenapharm、Lupin、Naari、Qinhuangdao Zizhu Pharmaceutical、Sterling Chemical Malta Ltd、Symbiotec Pharmalab、Yangzhou Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：短時間作用型避妊API、長時間作用型避妊API ・用途別分析2016年-2026年：テーブル、混合物製品、その他 ・レボノルゲストレルAPIの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・レボノルゲストレルAPIのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・レボノルゲストレルAPIのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・レボノルゲストレルAPIの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・レボノルゲストレルAPIの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Levonorgestrel API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Levonorgestrel API size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Levonorgestrel API market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Levonorgestrel API market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Short-Acting Contraceptive API
Long-Acting Contraceptive API
Market segment by Application can be divided into
Table
Mixture Products
Other
The key market players for global Levonorgestrel API market are listed below:
ScinoPharm
Altaris (3M Drug Delivery Systems)
Bayer
Cipla
Formos
FORTEQ NIDAU AG
Gedeon Richter
Hangzhou Longshine Bio-Tec
Hubei Gedian Humanwell Pharmaceutical
Indo Phyto Chemicals
Industriale Chimica
Jenapharm
Lupin
Naari
Qinhuangdao Zizhu Pharmaceutical
Sterling Chemical Malta Ltd
Symbiotec Pharmalab
Yangzhou Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Levonorgestrel API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Levonorgestrel API, with price, sales, revenue and global market share of Levonorgestrel API in 2018 and 2019.
Chapter 3, the Levonorgestrel API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levonorgestrel API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Levonorgestrel API market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Levonorgestrel API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Levonorgestrel API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Levonorgestrel API Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Short-Acting Contraceptive API
1.2.3 Long-Acting Contraceptive API
1.3 Market Analysis by Application
1.3.1 Overview: Global Levonorgestrel API Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Table
1.3.3 Mixture Products
1.3.4 Other
1.4 Global Levonorgestrel API Market Size & Forecast
1.4.1 Global Levonorgestrel API Sales in Value (2016-2026))
1.4.2 Global Levonorgestrel API Sales in Volume (2016-2026)
1.4.3 Global Levonorgestrel API Price by Type (2016-2026) & (US$/G)
1.5 Global Levonorgestrel API Production Capacity Analysis
1.5.1 Global Levonorgestrel API Total Production Capacity (2016-2026)
1.5.2 Global Levonorgestrel API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Levonorgestrel API Market Drivers
1.6.2 Levonorgestrel API Market Restraints
1.6.3 Levonorgestrel API Trends Analysis
2 Manufacturers Profiles
2.1 ScinoPharm
2.1.1 ScinoPharm Details
2.1.2 ScinoPharm Major Business
2.1.3 ScinoPharm Levonorgestrel API Product and Services
2.1.4 ScinoPharm Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Altaris (3M Drug Delivery Systems)
2.2.1 Altaris (3M Drug Delivery Systems) Details
2.2.2 Altaris (3M Drug Delivery Systems) Major Business
2.2.3 Altaris (3M Drug Delivery Systems) Levonorgestrel API Product and Services
2.2.4 Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Levonorgestrel API Product and Services
2.3.4 Bayer Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Levonorgestrel API Product and Services
2.4.4 Cipla Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Formos
2.5.1 Formos Details
2.5.2 Formos Major Business
2.5.3 Formos Levonorgestrel API Product and Services
2.5.4 Formos Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 FORTEQ NIDAU AG
2.6.1 FORTEQ NIDAU AG Details
2.6.2 FORTEQ NIDAU AG Major Business
2.6.3 FORTEQ NIDAU AG Levonorgestrel API Product and Services
2.6.4 FORTEQ NIDAU AG Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Levonorgestrel API Product and Services
2.7.4 Gedeon Richter Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Hangzhou Longshine Bio-Tec
2.8.1 Hangzhou Longshine Bio-Tec Details
2.8.2 Hangzhou Longshine Bio-Tec Major Business
2.8.3 Hangzhou Longshine Bio-Tec Levonorgestrel API Product and Services
2.8.4 Hangzhou Longshine Bio-Tec Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Hubei Gedian Humanwell Pharmaceutical
2.9.1 Hubei Gedian Humanwell Pharmaceutical Details
2.9.2 Hubei Gedian Humanwell Pharmaceutical Major Business
2.9.3 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Product and Services
2.9.4 Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Indo Phyto Chemicals
2.10.1 Indo Phyto Chemicals Details
2.10.2 Indo Phyto Chemicals Major Business
2.10.3 Indo Phyto Chemicals Levonorgestrel API Product and Services
2.10.4 Indo Phyto Chemicals Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Industriale Chimica
2.11.1 Industriale Chimica Details
2.11.2 Industriale Chimica Major Business
2.11.3 Industriale Chimica Levonorgestrel API Product and Services
2.11.4 Industriale Chimica Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Jenapharm
2.12.1 Jenapharm Details
2.12.2 Jenapharm Major Business
2.12.3 Jenapharm Levonorgestrel API Product and Services
2.12.4 Jenapharm Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Lupin
2.13.1 Lupin Details
2.13.2 Lupin Major Business
2.13.3 Lupin Levonorgestrel API Product and Services
2.13.4 Lupin Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Naari
2.14.1 Naari Details
2.14.2 Naari Major Business
2.14.3 Naari Levonorgestrel API Product and Services
2.14.4 Naari Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Qinhuangdao Zizhu Pharmaceutical
2.15.1 Qinhuangdao Zizhu Pharmaceutical Details
2.15.2 Qinhuangdao Zizhu Pharmaceutical Major Business
2.15.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product and Services
2.15.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Sterling Chemical Malta Ltd
2.16.1 Sterling Chemical Malta Ltd Details
2.16.2 Sterling Chemical Malta Ltd Major Business
2.16.3 Sterling Chemical Malta Ltd Levonorgestrel API Product and Services
2.16.4 Sterling Chemical Malta Ltd Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Symbiotec Pharmalab
2.17.1 Symbiotec Pharmalab Details
2.17.2 Symbiotec Pharmalab Major Business
2.17.3 Symbiotec Pharmalab Levonorgestrel API Product and Services
2.17.4 Symbiotec Pharmalab Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Yangzhou Pharmaceutical
2.18.1 Yangzhou Pharmaceutical Details
2.18.2 Yangzhou Pharmaceutical Major Business
2.18.3 Yangzhou Pharmaceutical Levonorgestrel API Product and Services
2.18.4 Yangzhou Pharmaceutical Levonorgestrel API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Levonorgestrel API Sales by Manufacturer
3.1 Global Levonorgestrel API Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Levonorgestrel API Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Levonorgestrel API
3.4 Market Concentration Rate
3.4.1 Top 3 Levonorgestrel API Manufacturer Market Share
3.4.2 Top 6 Levonorgestrel API Manufacturer Market Share
3.5 Global Levonorgestrel API Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Levonorgestrel API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Levonorgestrel API Market Size by Region
4.1.1 Global Levonorgestrel API Sales in Volume by Region (2016-2026)
4.1.2 Global Levonorgestrel API Revenue by Region (2016-2026)
4.2 North America Levonorgestrel API Revenue (2016-2026)
4.3 Europe Levonorgestrel API Revenue (2016-2026)
4.4 Asia-Pacific Levonorgestrel API Revenue (2016-2026)
4.5 South America Levonorgestrel API Revenue (2016-2026)
4.6 Middle East and Africa Levonorgestrel API Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Levonorgestrel API Sales in Volume by Type (2016-2026)
5.2 Global Levonorgestrel API Revenue by Type (2016-2026)
5.3 Global Levonorgestrel API Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Levonorgestrel API Sales in Volume by Application (2016-2026)
6.2 Global Levonorgestrel API Revenue by Application (2016-2026)
6.3 Global Levonorgestrel API Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Levonorgestrel API Sales by Type (2016-2026)
7.2 North America Levonorgestrel API Sales by Application (2016-2026)
7.3 North America Levonorgestrel API Market Size by Country
7.3.1 North America Levonorgestrel API Sales in Volume by Country (2016-2026)
7.3.2 North America Levonorgestrel API Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Levonorgestrel API Sales by Type (2016-2026)
8.2 Europe Levonorgestrel API Sales by Application (2016-2026)
8.3 Europe Levonorgestrel API Market Size by Country
8.3.1 Europe Levonorgestrel API Sales in Volume by Country (2016-2026)
8.3.2 Europe Levonorgestrel API Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Levonorgestrel API Sales by Type (2016-2026)
9.2 Asia-Pacific Levonorgestrel API Sales by Application (2016-2026)
9.3 Asia-Pacific Levonorgestrel API Market Size by Region
9.3.1 Asia-Pacific Levonorgestrel API Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Levonorgestrel API Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Levonorgestrel API Sales by Type (2016-2026)
10.2 South America Levonorgestrel API Sales by Application (2016-2026)
10.3 South America Levonorgestrel API Market Size by Country
10.3.1 South America Levonorgestrel API Sales in Volume by Country (2016-2026)
10.3.2 South America Levonorgestrel API Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Levonorgestrel API Sales by Type (2016-2026)
11.2 Middle East & Africa Levonorgestrel API Sales by Application (2016-2026)
11.3 Middle East & Africa Levonorgestrel API Market Size by Country
11.3.1 Middle East & Africa Levonorgestrel API Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Levonorgestrel API Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Levonorgestrel API Typical Distributors
12.3 Levonorgestrel API Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Levonorgestrel API Revenue by Type, (USD Million), 2021-2026
Table 2. Global Levonorgestrel API Revenue by Application, (USD Million), 2021-2026
Table 3. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 4. ScinoPharm Major Business
Table 5. ScinoPharm Levonorgestrel API Product and Services
Table 6. ScinoPharm Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Altaris (3M Drug Delivery Systems) Basic Information, Manufacturing Base and Competitors
Table 8. Altaris (3M Drug Delivery Systems) Major Business
Table 9. Altaris (3M Drug Delivery Systems) Levonorgestrel API Product and Services
Table 10. Altaris (3M Drug Delivery Systems) Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Levonorgestrel API Product and Services
Table 14. Bayer Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cipla Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Major Business
Table 17. Cipla Levonorgestrel API Product and Services
Table 18. Cipla Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Formos Basic Information, Manufacturing Base and Competitors
Table 20. Formos Major Business
Table 21. Formos Levonorgestrel API Product and Services
Table 22. Formos Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. FORTEQ NIDAU AG Basic Information, Manufacturing Base and Competitors
Table 24. FORTEQ NIDAU AG Major Business
Table 25. FORTEQ NIDAU AG Levonorgestrel API Product and Services
Table 26. FORTEQ NIDAU AG Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 28. Gedeon Richter Major Business
Table 29. Gedeon Richter Levonorgestrel API Product and Services
Table 30. Gedeon Richter Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Hangzhou Longshine Bio-Tec Basic Information, Manufacturing Base and Competitors
Table 32. Hangzhou Longshine Bio-Tec Major Business
Table 33. Hangzhou Longshine Bio-Tec Levonorgestrel API Product and Services
Table 34. Hangzhou Longshine Bio-Tec Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hubei Gedian Humanwell Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Hubei Gedian Humanwell Pharmaceutical Major Business
Table 37. Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Product and Services
Table 38. Hubei Gedian Humanwell Pharmaceutical Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Indo Phyto Chemicals Basic Information, Manufacturing Base and Competitors
Table 40. Indo Phyto Chemicals Major Business
Table 41. Indo Phyto Chemicals Levonorgestrel API Product and Services
Table 42. Indo Phyto Chemicals Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Industriale Chimica Basic Information, Manufacturing Base and Competitors
Table 44. Industriale Chimica Major Business
Table 45. Industriale Chimica Levonorgestrel API Product and Services
Table 46. Industriale Chimica Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Jenapharm Basic Information, Manufacturing Base and Competitors
Table 48. Jenapharm Major Business
Table 49. Jenapharm Levonorgestrel API Product and Services
Table 50. Jenapharm Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Lupin Basic Information, Manufacturing Base and Competitors
Table 52. Lupin Major Business
Table 53. Lupin Levonorgestrel API Product and Services
Table 54. Lupin Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Naari Basic Information, Manufacturing Base and Competitors
Table 56. Naari Major Business
Table 57. Naari Levonorgestrel API Product and Services
Table 58. Naari Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Qinhuangdao Zizhu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Qinhuangdao Zizhu Pharmaceutical Major Business
Table 61. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product and Services
Table 62. Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Sterling Chemical Malta Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Sterling Chemical Malta Ltd Major Business
Table 65. Sterling Chemical Malta Ltd Levonorgestrel API Product and Services
Table 66. Sterling Chemical Malta Ltd Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Symbiotec Pharmalab Basic Information, Manufacturing Base and Competitors
Table 68. Symbiotec Pharmalab Major Business
Table 69. Symbiotec Pharmalab Levonorgestrel API Product and Services
Table 70. Symbiotec Pharmalab Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Yangzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Yangzhou Pharmaceutical Major Business
Table 73. Yangzhou Pharmaceutical Levonorgestrel API Product and Services
Table 74. Yangzhou Pharmaceutical Levonorgestrel API Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Levonorgestrel API Sales by Manufacturer (2019-2021e) & (KG)
Table 76. Global Levonorgestrel API Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Levonorgestrel API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Levonorgestrel API Production Capacity by Company, (KG): 2020 VS 2021
Table 79. Head Office and Levonorgestrel API Production Site of Key Manufacturer
Table 80. Levonorgestrel API New Entrant and Capacity Expansion Plans
Table 81. Levonorgestrel API Mergers & Acquisitions in the Past Five Years
Table 82. Global Levonorgestrel API Sales by Region (2016-2021e) & (KG)
Table 83. Global Levonorgestrel API Sales by Region (2021-2026) & (KG)
Table 84. Global Levonorgestrel API Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Levonorgestrel API Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Levonorgestrel API Sales by Type (2016-2021e) & (KG)
Table 87. Global Levonorgestrel API Sales by Type (2021-2026) & (KG)
Table 88. Global Levonorgestrel API Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Levonorgestrel API Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Levonorgestrel API Price by Type (2016-2021e) & (US$/G)
Table 91. Global Levonorgestrel API Price by Type (2021-2026) & (US$/G)
Table 92. Global Levonorgestrel API Sales by Application (2016-2021e) & (KG)
Table 93. Global Levonorgestrel API Sales by Application (2021-2026) & (KG)
Table 94. Global Levonorgestrel API Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Levonorgestrel API Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Levonorgestrel API Price by Application (2016-2021e) & (US$/G)
Table 97. Global Levonorgestrel API Price by Application (2021-2026) & (US$/G)
Table 98. North America Levonorgestrel API Sales by Country (2016-2021e) & (KG)
Table 99. North America Levonorgestrel API Sales by Country (2021-2026) & (KG)
Table 100. North America Levonorgestrel API Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Levonorgestrel API Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Levonorgestrel API Sales by Type (2016-2021e) & (KG)
Table 103. North America Levonorgestrel API Sales by Type (2021-2026) & (KG)
Table 104. North America Levonorgestrel API Sales by Application (2016-2021e) & (KG)
Table 105. North America Levonorgestrel API Sales by Application (2021-2026) & (KG)
Table 106. Europe Levonorgestrel API Sales by Country (2016-2021e) & (KG)
Table 107. Europe Levonorgestrel API Sales by Country (2021-2026) & (KG)
Table 108. Europe Levonorgestrel API Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Levonorgestrel API Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Levonorgestrel API Sales by Type (2016-2021e) & (KG)
Table 111. Europe Levonorgestrel API Sales by Type (2021-2026) & (KG)
Table 112. Europe Levonorgestrel API Sales by Application (2016-2021e) & (KG)
Table 113. Europe Levonorgestrel API Sales by Application (2021-2026) & (KG)
Table 114. Asia-Pacific Levonorgestrel API Sales by Region (2016-2021e) & (KG)
Table 115. Asia-Pacific Levonorgestrel API Sales by Region (2021-2026) & (KG)
Table 116. Asia-Pacific Levonorgestrel API Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Levonorgestrel API Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Levonorgestrel API Sales by Type (2016-2021e) & (KG)
Table 119. Asia-Pacific Levonorgestrel API Sales by Type (2021-2026) & (KG)
Table 120. Asia-Pacific Levonorgestrel API Sales by Application (2016-2021e) & (KG)
Table 121. Asia-Pacific Levonorgestrel API Sales by Application (2021-2026) & (KG)
Table 122. South America Levonorgestrel API Sales by Country (2016-2021e) & (KG)
Table 123. South America Levonorgestrel API Sales by Country (2021-2026) & (KG)
Table 124. South America Levonorgestrel API Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Levonorgestrel API Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Levonorgestrel API Sales by Type (2016-2021e) & (KG)
Table 127. South America Levonorgestrel API Sales by Type (2021-2026) & (KG)
Table 128. South America Levonorgestrel API Sales by Application (2016-2021e) & (KG)
Table 129. South America Levonorgestrel API Sales by Application (2021-2026) & (KG)
Table 130. Middle East & Africa Levonorgestrel API Sales by Country (2016-2021e) & (KG)
Table 131. Middle East & Africa Levonorgestrel API Sales by Country (2021-2026) & (KG)
Table 132. Middle East & Africa Levonorgestrel API Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Levonorgestrel API Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Levonorgestrel API Sales by Type (2016-2021e) & (KG)
Table 135. Middle East & Africa Levonorgestrel API Sales by Type (2021-2026) & (KG)
Table 136. Middle East & Africa Levonorgestrel API Sales by Application (2016-2021e) & (KG)
Table 137. Middle East & Africa Levonorgestrel API Sales by Application (2021-2026) & (KG)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Levonorgestrel API Typical Distributors
Table 141. Levonorgestrel API Typical Customers
List of Figures
Figure 1. Levonorgestrel API Picture
Figure 2. Global Levonorgestrel API Sales Market Share by Type in 2020
Figure 3. Short-Acting Contraceptive API
Figure 4. Long-Acting Contraceptive API
Figure 5. Global Levonorgestrel API Sales Market Share by Application in 2020
Figure 6. Table
Figure 7. Mixture Products
Figure 8. Other
Figure 9. Global Levonorgestrel API Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 10. Global Levonorgestrel API Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Levonorgestrel API Sales (2016-2026) & (KG)
Figure 12. Global Levonorgestrel API Price by Type (2016-2026) & (US$/G)
Figure 13. Global Levonorgestrel API Production Capacity (2016-2026) & (KG)
Figure 14. Global Levonorgestrel API Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Levonorgestrel API Market Drivers
Figure 16. Levonorgestrel API Market Restraints
Figure 17. Levonorgestrel API Market Trends
Figure 18. Global Levonorgestrel API Sales Market Share by Manufacturer in 2020
Figure 19. Global Levonorgestrel API Revenue Market Share by Manufacturer in 2020
Figure 20. Levonorgestrel API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Levonorgestrel API Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Levonorgestrel API Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Levonorgestrel API Sales Market Share by Region (2016-2026)
Figure 24. Global Levonorgestrel API Revenue Market Share by Region (2016-2026)
Figure 25. North America Levonorgestrel API Revenue (2016-2026) & (USD Million)
Figure 26. Europe Levonorgestrel API Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Levonorgestrel API Revenue (2016-2026) & (USD Million)
Figure 28. South America Levonorgestrel API Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Levonorgestrel API Revenue (2016-2026) & (USD Million)
Figure 30. Global Levonorgestrel API Sales Market Share by Type (2016-2026)
Figure 31. Global Levonorgestrel API Revenue Market Share by Type (2016-2026)
Figure 32. Global Levonorgestrel API Price by Type (2016-2026) & (US$/G)
Figure 33. Global Levonorgestrel API Sales Market Share by Application (2016-2026)
Figure 34. Global Levonorgestrel API Revenue Market Share by Application (2016-2026)
Figure 35. Global Levonorgestrel API Price by Application (2016-2026) & (US$/G)
Figure 36. North America Levonorgestrel API Sales Market Share by Type (2016-2026)
Figure 37. North America Levonorgestrel API Sales Market Share by Application (2016-2026)
Figure 38. North America Levonorgestrel API Sales Market Share by Country (2016-2026)
Figure 39. North America Levonorgestrel API Revenue Market Share by Country (2016-2026)
Figure 40. United States Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Levonorgestrel API Sales Market Share by Type (2016-2026)
Figure 44. Europe Levonorgestrel API Sales Market Share by Application (2016-2026)
Figure 45. Europe Levonorgestrel API Sales Market Share by Country (2016-2026)
Figure 46. Europe Levonorgestrel API Revenue Market Share by Country (2016-2026)
Figure 47. Germany Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Levonorgestrel API Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Levonorgestrel API Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Levonorgestrel API Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Levonorgestrel API Revenue Market Share by Region (2016-2026)
Figure 56. China Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Levonorgestrel API Sales Market Share by Type (2016-2026)
Figure 63. South America Levonorgestrel API Sales Market Share by Application (2016-2026)
Figure 64. South America Levonorgestrel API Sales Market Share by Country (2016-2026)
Figure 65. South America Levonorgestrel API Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Levonorgestrel API Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Levonorgestrel API Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Levonorgestrel API Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Levonorgestrel API Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Levonorgestrel API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
レボノルゲストレルの世界市場2018-2025 Levonorgestrel is a hormonal medication which is used in a number of birth control methods.In 2018, the global Levonorgestrel market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018…- エチニルエストラジオール・レボノルゲストレルの世界市場2018-2025 This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen).The Ethinyl estradiol and levonorgestrel market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR …
- 世界の経口避妊薬市場 2021：企業別、地域別、種類・用途別 The Oral Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の反転型ラプチャーディスク市場 2021：企業別、地域別、種類・用途別 The Reverse Acting Rupture Discs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の間接作動圧力計市場 2021：企業別、地域別、種類・用途別 The Indirect Acting Pressure Gauge market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …